Table 3.
Costs of HepFriend intervention activities for financial year 2017/18
| Activities for financial year 2017/18 | Base case cost (£) 2017/18 | Model input | |
|---|---|---|---|
| Total cost | 128136.70 | ||
| Total cost of outreach activities (includes staff time, travel, training and a proportion of overheads) | in outreach location | 16202.85 | total cost of diagnosis (1 year), £61132.55 |
| in mobile health unit (includes capital and recurrent vehicle costs) | 24454.91 | ||
| informing HCV patients of their status | 4999.31 | ||
| Total cost of tests (includes administrative and management, staff time, medical supplies and test costs) | POCT (98 tests for the year) | 6942.41 | |
| DBS RNA (62 tests for the year) | 8533.07 | ||
| FibroScan (includes staff time and capital cost) | 15142.15 | total cost of engagement (1 year), £36338.79 + hospital clinic costs | |
| Engagement of RNA+ patients (follow-up of RNA+ tests) | 7908.27 | ||
| Peer support for evaluation visit in hospital | peer support costs | 13288.37 | |
| Peer support for initiating treatment and subsequent treatment visits 0, 2, 4, 6, 8, 10 weeks | peer support costs | 14111.91 | total cost of treatment for 1 year (not including cost of DAA drugs), £30665.35 + hospital clinic costs + DAAs |
| Adherence support | 8289.22 | ||
| Peer support for post-treatment visits at 12 weeks and 1 year | peer support costs | 8264.22 | |
From UCLH and Groundswell records.